"10.1371_journal.pone.0081835","plos one","2013-12-13T00:00:00Z","Lise Weis; Marie Metzger; Jean-Philippe Haymann; Eric Thervet; Martin Flamant; François Vrtovsnik; Cédric Gauci; Pascal Houillier; Marc Froissart; Emmanuel Letavernier; Bénédicte Stengel; Jean-Jacques Boffa; on behalf of the NephroTest Study Group","Department of Nephrology, AP-HP, Hôpital Tenon, Paris, France; Research Centre in Epidemiology and Population Health, Inserm Unit 1018, CESP, Villejuif, France; UMRS 1018, Univ Paris-Sud, Villejuif, France; Department of Physiology, AP-HP, Hôpital Tenon, Paris, France; INSERM UNIT 702, Paris, France; UMR S 702, Univ Pierre et Marie Curie-Paris 6, Paris, France; Department of Nephrology, AP-HP, Hôpital Européen Georges Pompidou, Paris, France; UMR S 775, Univ Paris Descartes, Paris, France; Department of Physiology, AP-HP, Hôpital Bichat, Paris, France; Department of Nephrology, AP-HP, Hôpital Bichat, Paris, France; Department Physiology, AP-HP, Hôpital Européen Georges Pompidou, Paris, France","¶ Membership of the NephroTest Study Group is provided in the Acknowledgments.","Marc Froisart has received consulting or lecture fees or research funds from Affymax, Genzyme, Hoffmann-La Roche, Novartis, Sandoz, Shire, Takeda, and Vifor International. Marc Froisart has been employed by Amgen since January 1, 2011, but was a full-time academic associate professor during the time of study conception and data collection. Bénédicte Stengel has received research funds from Amgen, Baxter, Genzyme (Sanofi), Fresenius, MSD, and GSK. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Lise Weis","LW",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
